The award recognizes innovations in biomedicine and was given to a system jointly engineered by Lincoln Laboratory that allows surgeons to see fluorescent carbon nanotubes bound to tumors.
April 6, 2020

Angela Belcher, chair of MIT’s Department of Biological Engineering, and her team tackled the daunting challenge of ovarian cancer, which owes its disappointing survival rates to late detection, usually after the initial cancer cells have spread like wildfire from the ovary to other organs and tissues throughout the abdomen.

Working with oncologists from Harvard-affiliated hospitals and engineers at MIT’s Lincoln Laboratory, they developed a system that manipulates carbon nanotubes so they fluoresce in the wavelengths needed to penetrate tissue deep inside the body.